Successful long-term management of adenomyosis associated with deep thrombosis by low-dose gonadotropin-releasing hormone agonist therapy

Clinical and Experimental Obstetrics and Gynecology

Volumn 36, Issue 2, 2009, Pages 123-125

  Akira, S ^a   Iwasaki, N ^a   Ichikawa, M ^a   Mine, K ^a   Kuwabara, Y ^a   Takeshita, T ^a   Tajima, H ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Adenomyosis; Deep thorombosis; Estrogen deficiency symptoms; GnRH agonist

Indexed keywords

BUSERELIN ACETATE; CA 125 ANTIGEN; ESTRADIOL; GONADORELIN AGONIST; HEPARIN; LEUPRORELIN; UROKINASE; WARFARIN;

ADENOMYOSIS; ADULT; ARTICLE; BONE DENSITY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DISEASE COURSE; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE REDUCTION; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; FIBRINOLYTIC THERAPY; HORMONAL THERAPY; HUMAN; LEG PHLEBOGRAPHY; LONG TERM CARE; LOW DRUG DOSE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NULLIPARA; PROTEIN BLOOD LEVEL; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADULT; BUSERELIN; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIOSIS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEUPROLIDE; VENOUS THROMBOSIS;

EID: 67649821791     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Grow D.R., Filer R.B.: "Treatment of adenomyosis with long-term GnRH-analogues: a case report". Obstet. Gynecol., 1991, 78, 538.
2. Nelson J.R., Corson S.L.: "Long-term management of adenomyosis with a gonadotropin releasing hormone agonist". Fertil. Steril., 1993, 59, 441. (Pubitemid 23057803)
3. Comite F.: "GnRH analogs and safety". Obstet. Gynecol. Surv., 1989, 44, 319.
4. Barbieri R.L.: "Hormone treatment of endometriosis: the estrogen threshold hypothesis". Am. J. Obstet. Gynecol., 1992, 166, 740.
5. Monroe S.E., Blumenfeld Z., Andreyko J.L., Schriock E., Henzl M.R., Jaffe R.B.: "Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin)". J. Clin. Endocrinol. Metab., 1986, 63, 1334. (Pubitemid 17206426)
6. Jacobson J., Harris S.R., Bullingham R.E.: "Low dose intranasal nafarelin for the treatment of endometriosis". Acta Obstet. Gynecol. Scand., 1994, 73, 144. (Pubitemid 24064089)
7. Uemura T., Shimoda H., Katagiri N., Asukai K., Suzuki N., Osada H. et al.: "Low-dose GnRH agonist therapy for the management of endometriosis". J. Obstet. Gynaecol. Res., 1999, 25, 295. (Pubitemid 29500367)
8. Tahara M., Matsumoto T., Yokoi T., Tasaka K., Kurachi H., Murata Y.: "Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy ("draw-back") therapy". Fertil. Steril., 2000, 73, 799. (Pubitemid 30154121)
9. Makita K., Ishitani K., Ohta H., Horiguchi F., Nozawa S.: "Long-term effect on bone mineral density and bone metabolism of 6 months' treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate". J. Bone Miner. Metab., 2005, 23, 389. (Pubitemid 41223802)
10. Uemura T., Mohri J., Osada H., Suzuki N., Katagiri N., Minaguchi H.: "Effect of gonadotropin-releasing hormone agonist on the bone mineral content of patients with endometriosis". Fertil. Steril., 1994, 62, 246. (Pubitemid 24233270)